NDC 65862-243

Atomoxetine

Atomoxetine

Atomoxetine is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is Atomoxetine Hydrochloride.

Product ID65862-243_72dacd9e-8d0e-4d83-a5ea-d4dc65f93c97
NDC65862-243
Product TypeHuman Prescription Drug
Proprietary NameAtomoxetine
Generic NameAtomoxetine
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2017-05-30
Marketing CategoryANDA / DRUG FOR FURTHER PROCESSING
Application NumberANDA079016
Labeler NameAurobindo Pharma Limited
Substance NameATOMOXETINE HYDROCHLORIDE
Active Ingredient Strength80 mg/1
Pharm ClassesNorepinephrine Reuptake Inhibitor [EPC],Norepinephrine Uptake Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 65862-243-05

500 CAPSULE in 1 BOTTLE (65862-243-05)
Marketing Start Date2017-05-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 65862-243-05 [65862024305]

Atomoxetine CAPSULE
Marketing CategoryANDA
Application NumberANDA079016
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-05-30

NDC 65862-243-26 [65862024326]

Atomoxetine CAPSULE
Marketing CategoryANDA
Application NumberANDA079016
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-05-30
Marketing End Date2012-06-05

NDC 65862-243-22 [65862024322]

Atomoxetine CAPSULE
Marketing CategoryANDA
Application NumberANDA079016
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-06-05
Marketing End Date2017-05-31

NDC 65862-243-30 [65862024330]

Atomoxetine CAPSULE
Marketing CategoryANDA
Application NumberANDA079016
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-05-30

Drug Details

Active Ingredients

IngredientStrength
ATOMOXETINE HYDROCHLORIDE80 mg/1

NDC Crossover Matching brand name "Atomoxetine" or generic name "Atomoxetine"

NDCBrand NameGeneric Name
0093-3542AtomoxetineAtomoxetine
0093-3543AtomoxetineAtomoxetine
0093-3544AtomoxetineAtomoxetine
0093-3545AtomoxetineAtomoxetine
0093-3546AtomoxetineAtomoxetine
0093-3547AtomoxetineAtomoxetine
68382-217atomoxetineatomoxetine
68382-220atomoxetineatomoxetine
68382-218atomoxetineatomoxetine
68382-219atomoxetineatomoxetine
68382-223atomoxetineatomoxetine
68382-216atomoxetineatomoxetine
68462-266atomoxetineatomoxetine
68462-265atomoxetineatomoxetine
68462-270atomoxetineatomoxetine
68462-269atomoxetineatomoxetine
68462-267atomoxetineatomoxetine
68462-268atomoxetineatomoxetine
68462-271atomoxetineatomoxetine
0093-3548AtomoxetineAtomoxetine
16714-761atomoxetineatomoxetine
16714-755atomoxetineatomoxetine
16714-758atomoxetineatomoxetine
16714-759atomoxetineatomoxetine
16714-756atomoxetineatomoxetine
16714-760atomoxetineatomoxetine
16714-757atomoxetineatomoxetine
55111-563AtomoxetineAtomoxetine
55111-564AtomoxetineAtomoxetine
55111-520AtomoxetineAtomoxetine
55111-521AtomoxetineAtomoxetine
55111-519AtomoxetineAtomoxetine
55111-522AtomoxetineAtomoxetine
55111-528AtomoxetineAtomoxetine
60687-326AtomoxetineAtomoxetine
64980-375AtomoxetineAtomoxetine
64980-379AtomoxetineAtomoxetine
64980-374AtomoxetineAtomoxetine
64980-376AtomoxetineAtomoxetine
64980-377AtomoxetineAtomoxetine
64980-378AtomoxetineAtomoxetine
64980-373AtomoxetineAtomoxetine
65862-243AtomoxetineAtomoxetine
65862-238AtomoxetineAtomoxetine
65841-608atomoxetineatomoxetine
65841-607atomoxetineatomoxetine
65841-610atomoxetineatomoxetine
65862-239AtomoxetineAtomoxetine
65862-241AtomoxetineAtomoxetine
65862-242AtomoxetineAtomoxetine
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.